Kenya has been given $70 million from the Global Fund to fund programmes providing antiretroviral (ARV) drugs to people living with HIV.
According to the latest government statistics, the east African country has an estimated 1.3 million people living with the virus despite the prevalence for AIDS dropping from 14 percent in 2000 to 6.9 percent in 2006.
In June this year Kenya's President Mwai Kibaki promised the government would start providing free ARVs to government hospitals and health centres, and currently 120,000 people are receiving the life prolonging drugs.
However there are not enough ARVs in public health centres and many Kenyans who live on less than one dollar a day cannot afford to buy the drugs in private hospitals.
The three year grant is the second phase of funding from the global body, which leads in the fight against AIDS, tuberculosis and malaria.
Kenya's share will be 29 percent of the total HIV/AIDS funds approved in the second phase worldwide.
The Global Fund was established in 2004 and is the largest international financier of efforts to control malaria and tuberculosis and ranks among the top three funders of AIDS programmes.
This latest funding represents a follow-up to a three year $37 million grant that ended this year amid concerns that Kenya had submitted audit documents too late to receive a final $10 million disbursement.